世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

臨床試験機器および付属ソリューションの世界市場インサイト、2029年までの予測


Global Clinical Trial Equipment & Ancillary Solutions Market Insights, Forecast to 2029

市場分析と洞察:臨床試験機器と付属ソリューションの世界市場 世界の臨床試験機器および付属ソリューション市場は、予測期間中に年平均成長率(CAGR)%で、2023年の百万米ドルから2029年には百万米ドルに成長す... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2023年8月9日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

市場分析と洞察:臨床試験機器と付属ソリューションの世界市場
世界の臨床試験機器および付属ソリューション市場は、予測期間中に年平均成長率(CAGR)%で、2023年の百万米ドルから2029年には百万米ドルに成長すると予測される。
米国とカナダの臨床試験機器 & 補助ソリューション市場は、2023年の100万米ドルから2029年には100万米ドルに達すると予測され、2023年から2029年の予測期間中に年平均成長率 (CAGR) %で増加すると予測されます。
臨床試験機器と付属ソリューションの中国市場は、2023年の100万ドルから2029年には100万ドルに達すると推定され、2023年から2029年の予測期間中の年平均成長率は%である。
臨床試験機器&付属ソリューションのヨーロッパ市場は、2023年の100万ドルから2029年には100万ドルに達すると推定され、2023年から2029年の予測期間中の年平均成長率は%である。
臨床試験機器&補助ソリューションの世界の主要企業には、Almac、Ancillare、Avantor、Emsere、Eurofins Scientific、Imperial Clinical Research Services、IRM Europe、Marken、Myonexなどが含まれます。

レポートの内容
本レポートでは、臨床試験機器および付属ソリューションの世界市場規模について概観します。2018年~2022年の過去の市場収益データ、2023年の予測、2029年までのCAGR予測による世界市場動向の分析。
本レポートでは、臨床試験機器および付属ソリューションの主要生産者を調査し、主要地域および国の収益も掲載しています。臨床試験機器および付属ソリューションの今後の市場ポテンシャルと、この市場を様々なセグメントおよびサブセグメントに予測するための主要地域/国に焦点を当てたハイライト。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他の国々の国別データと市場価値分析。

本レポートでは、2018年から2023年までのデータで、主要企業の臨床試験機器&付属ソリューションの収益、市場シェア、業界ランキングに焦点を当てています。世界の臨床試験機器&アンシラリーソリューション市場における主要なステークホルダーを特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づいて分析します。本レポートは、利害関係者が競争状況を理解し、より多くの洞察を得て、より良い方法で事業と市場戦略を位置づけるのに役立ちます。
本レポートでは、2018年から2029年までのタイプ別、用途別のセグメントデータ、収益、成長率を分析しています。臨床試験機器・補助ソリューションの収益、予測成長動向、生産技術、用途、エンドユーザー産業の市場規模を評価・予測します。
Almac、Ancillare、Avantor、Emsere、Eurofins Scientific、Imperial Clinical Research Services、IRM Europe、Marken、Myonexなど、世界の主要企業の詳細な企業プロフィール。

企業別
アルマック
アンシラーレ
アバンター
エムセレ
ユーロフィンズサイエンティフィック
インペリアル・クリニカル・リサーチ・サービス
IRMヨーロッパ
マーケン
マイオネックス
パレクセル・インターナショナル
ピラマル・ファーマ
レシファーム
サーモフィッシャーサイエンティフィック
ウッドリー機器
クイップメントSAS
タイプ別セグメント
生物学的製剤
低分子医薬品
医療機器
用途別セグメント
医薬品開発業務受託機関(CRO)
医療機器メーカー
製薬・バイオテクノロジー企業
地域別
北米
米国
カナダ
欧州
ドイツ
フランス
英国
イタリア
ロシア
北欧諸国
その他のヨーロッパ諸国
アジア太平洋
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中東、アフリカ、中南米
トルコ
サウジアラビア
アラブ首長国連邦
その他のMEA

各章の概要
第1章: レポートのスコープ、各市場セグメント(製品タイプ、用途など)の市場規模、今後の発展可能性などのエグゼクティブサマリーを紹介。市場の現状と、短期・中期・長期的な展開の可能性についてハイレベルな見解を提供しています。
第2章: 臨床試験機器および付属ソリューションの世界および地域レベルでの収益各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展見通し、市場スペース、生産能力などを紹介しています。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界各社が直面する課題とリスク、業界の関連政策の分析についても紹介しています。
第3章: 臨床試験機器・補助ソリューション企業の競争環境、収益、市場シェア、業界ランキング、最新の開発計画、合併・買収情報などを詳細に分析。
第4章:各種市場セグメントをタイプ別に分析し、各市場セグメントの収益、発展の可能性を網羅し、読者が各市場セグメントにおけるブルーオーシャン市場を見つけるのに役立つ。
第5章:アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの収益、発展の可能性をカバーし、読者が異なる下流市場のブルーオーシャン市場を見つけるのを助ける。
第6章:北米:タイプ別、用途別、国別、セグメント別の収益。
第7章:ヨーロッパ:タイプ別、用途別、国別、セグメント別収益。
第8章:中国:タイプ別、用途別、セグメント別収益。
第9章:アジア(中国を除く):タイプ別、用途別、地域別、セグメント別収益。
第10章:中東、アフリカ、ラテンアメリカ:タイプ別、用途別、国別、セグメント別収益。
第11章:主要企業のプロフィールを提供し、製品の説明や仕様、臨床試験機器&付随ソリューションの収益、売上総利益率、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介する。
第12章:アナリストの視点/結論


ページTOPに戻る


目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Trial Equipment & Ancillary Solutions Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Biologic Drugs
1.2.3 Small Molecules
1.2.4 Medical Devices
1.3 Market by Application
1.3.1 Global Clinical Trial Equipment & Ancillary Solutions Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Contract Research Organizations (CROs)
1.3.3 Medical Devices Companies
1.3.4 Pharmaceutical & Biotechnology Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Trial Equipment & Ancillary Solutions Market Perspective (2018-2029)
2.2 Global Clinical Trial Equipment & Ancillary Solutions Growth Trends by Region
2.2.1 Clinical Trial Equipment & Ancillary Solutions Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Clinical Trial Equipment & Ancillary Solutions Historic Market Size by Region (2018-2023)
2.2.3 Clinical Trial Equipment & Ancillary Solutions Forecasted Market Size by Region (2024-2029)
2.3 Clinical Trial Equipment & Ancillary Solutions Market Dynamics
2.3.1 Clinical Trial Equipment & Ancillary Solutions Industry Trends
2.3.2 Clinical Trial Equipment & Ancillary Solutions Market Drivers
2.3.3 Clinical Trial Equipment & Ancillary Solutions Market Challenges
2.3.4 Clinical Trial Equipment & Ancillary Solutions Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Clinical Trial Equipment & Ancillary Solutions by Players
3.1.1 Global Clinical Trial Equipment & Ancillary Solutions Revenue by Players (2018-2023)
3.1.2 Global Clinical Trial Equipment & Ancillary Solutions Revenue Market Share by Players (2018-2023)
3.2 Global Clinical Trial Equipment & Ancillary Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Clinical Trial Equipment & Ancillary Solutions, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Clinical Trial Equipment & Ancillary Solutions Market Concentration Ratio
3.4.1 Global Clinical Trial Equipment & Ancillary Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Trial Equipment & Ancillary Solutions Revenue in 2022
3.5 Global Key Players of Clinical Trial Equipment & Ancillary Solutions Head office and Area Served
3.6 Global Key Players of Clinical Trial Equipment & Ancillary Solutions, Product and Application
3.7 Global Key Players of Clinical Trial Equipment & Ancillary Solutions, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Trial Equipment & Ancillary Solutions Breakdown Data by Type
4.1 Global Clinical Trial Equipment & Ancillary Solutions Historic Market Size by Type (2018-2023)
4.2 Global Clinical Trial Equipment & Ancillary Solutions Forecasted Market Size by Type (2024-2029)
5 Clinical Trial Equipment & Ancillary Solutions Breakdown Data by Application
5.1 Global Clinical Trial Equipment & Ancillary Solutions Historic Market Size by Application (2018-2023)
5.2 Global Clinical Trial Equipment & Ancillary Solutions Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Clinical Trial Equipment & Ancillary Solutions Market Size (2018-2029)
6.2 North America Clinical Trial Equipment & Ancillary Solutions Market Size by Type
6.2.1 North America Clinical Trial Equipment & Ancillary Solutions Market Size by Type (2018-2023)
6.2.2 North America Clinical Trial Equipment & Ancillary Solutions Market Size by Type (2024-2029)
6.2.3 North America Clinical Trial Equipment & Ancillary Solutions Market Share by Type (2018-2029)
6.3 North America Clinical Trial Equipment & Ancillary Solutions Market Size by Application
6.3.1 North America Clinical Trial Equipment & Ancillary Solutions Market Size by Application (2018-2023)
6.3.2 North America Clinical Trial Equipment & Ancillary Solutions Market Size by Application (2024-2029)
6.3.3 North America Clinical Trial Equipment & Ancillary Solutions Market Share by Application (2018-2029)
6.4 North America Clinical Trial Equipment & Ancillary Solutions Market Size by Country
6.4.1 North America Clinical Trial Equipment & Ancillary Solutions Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2018-2023)
6.4.3 North America Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Clinical Trial Equipment & Ancillary Solutions Market Size (2018-2029)
7.2 Europe Clinical Trial Equipment & Ancillary Solutions Market Size by Type
7.2.1 Europe Clinical Trial Equipment & Ancillary Solutions Market Size by Type (2018-2023)
7.2.2 Europe Clinical Trial Equipment & Ancillary Solutions Market Size by Type (2024-2029)
7.2.3 Europe Clinical Trial Equipment & Ancillary Solutions Market Share by Type (2018-2029)
7.3 Europe Clinical Trial Equipment & Ancillary Solutions Market Size by Application
7.3.1 Europe Clinical Trial Equipment & Ancillary Solutions Market Size by Application (2018-2023)
7.3.2 Europe Clinical Trial Equipment & Ancillary Solutions Market Size by Application (2024-2029)
7.3.3 Europe Clinical Trial Equipment & Ancillary Solutions Market Share by Application (2018-2029)
7.4 Europe Clinical Trial Equipment & Ancillary Solutions Market Size by Country
7.4.1 Europe Clinical Trial Equipment & Ancillary Solutions Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2018-2023)
7.4.3 Europe Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Clinical Trial Equipment & Ancillary Solutions Market Size (2018-2029)
8.2 China Clinical Trial Equipment & Ancillary Solutions Market Size by Type
8.2.1 China Clinical Trial Equipment & Ancillary Solutions Market Size by Type (2018-2023)
8.2.2 China Clinical Trial Equipment & Ancillary Solutions Market Size by Type (2024-2029)
8.2.3 China Clinical Trial Equipment & Ancillary Solutions Market Share by Type (2018-2029)
8.3 China Clinical Trial Equipment & Ancillary Solutions Market Size by Application
8.3.1 China Clinical Trial Equipment & Ancillary Solutions Market Size by Application (2018-2023)
8.3.2 China Clinical Trial Equipment & Ancillary Solutions Market Size by Application (2024-2029)
8.3.3 China Clinical Trial Equipment & Ancillary Solutions Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Clinical Trial Equipment & Ancillary Solutions Market Size (2018-2029)
9.2 Asia Clinical Trial Equipment & Ancillary Solutions Market Size by Type
9.2.1 Asia Clinical Trial Equipment & Ancillary Solutions Market Size by Type (2018-2023)
9.2.2 Asia Clinical Trial Equipment & Ancillary Solutions Market Size by Type (2024-2029)
9.2.3 Asia Clinical Trial Equipment & Ancillary Solutions Market Share by Type (2018-2029)
9.3 Asia Clinical Trial Equipment & Ancillary Solutions Market Size by Application
9.3.1 Asia Clinical Trial Equipment & Ancillary Solutions Market Size by Application (2018-2023)
9.3.2 Asia Clinical Trial Equipment & Ancillary Solutions Market Size by Application (2024-2029)
9.3.3 Asia Clinical Trial Equipment & Ancillary Solutions Market Share by Application (2018-2029)
9.4 Asia Clinical Trial Equipment & Ancillary Solutions Market Size by Region
9.4.1 Asia Clinical Trial Equipment & Ancillary Solutions Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Clinical Trial Equipment & Ancillary Solutions Market Size by Region (2018-2023)
9.4.3 Asia Clinical Trial Equipment & Ancillary Solutions Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Clinical Trial Equipment & Ancillary Solutions Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Clinical Trial Equipment & Ancillary Solutions Market Size by Type
10.2.1 Middle East, Africa, and Latin America Clinical Trial Equipment & Ancillary Solutions Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Clinical Trial Equipment & Ancillary Solutions Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Clinical Trial Equipment & Ancillary Solutions Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Clinical Trial Equipment & Ancillary Solutions Market Size by Application
10.3.1 Middle East, Africa, and Latin America Clinical Trial Equipment & Ancillary Solutions Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Clinical Trial Equipment & Ancillary Solutions Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Clinical Trial Equipment & Ancillary Solutions Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Clinical Trial Equipment & Ancillary Solutions Market Size by Country
10.4.1 Middle East, Africa, and Latin America Clinical Trial Equipment & Ancillary Solutions Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Almac
11.1.1 Almac Company Details
11.1.2 Almac Business Overview
11.1.3 Almac Clinical Trial Equipment & Ancillary Solutions Introduction
11.1.4 Almac Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2018-2023)
11.1.5 Almac Recent Developments
11.2 Ancillare
11.2.1 Ancillare Company Details
11.2.2 Ancillare Business Overview
11.2.3 Ancillare Clinical Trial Equipment & Ancillary Solutions Introduction
11.2.4 Ancillare Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2018-2023)
11.2.5 Ancillare Recent Developments
11.3 Avantor
11.3.1 Avantor Company Details
11.3.2 Avantor Business Overview
11.3.3 Avantor Clinical Trial Equipment & Ancillary Solutions Introduction
11.3.4 Avantor Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2018-2023)
11.3.5 Avantor Recent Developments
11.4 Emsere
11.4.1 Emsere Company Details
11.4.2 Emsere Business Overview
11.4.3 Emsere Clinical Trial Equipment & Ancillary Solutions Introduction
11.4.4 Emsere Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2018-2023)
11.4.5 Emsere Recent Developments
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Details
11.5.2 Eurofins Scientific Business Overview
11.5.3 Eurofins Scientific Clinical Trial Equipment & Ancillary Solutions Introduction
11.5.4 Eurofins Scientific Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2018-2023)
11.5.5 Eurofins Scientific Recent Developments
11.6 Imperial Clinical Research Services
11.6.1 Imperial Clinical Research Services Company Details
11.6.2 Imperial Clinical Research Services Business Overview
11.6.3 Imperial Clinical Research Services Clinical Trial Equipment & Ancillary Solutions Introduction
11.6.4 Imperial Clinical Research Services Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2018-2023)
11.6.5 Imperial Clinical Research Services Recent Developments
11.7 IRM Europe
11.7.1 IRM Europe Company Details
11.7.2 IRM Europe Business Overview
11.7.3 IRM Europe Clinical Trial Equipment & Ancillary Solutions Introduction
11.7.4 IRM Europe Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2018-2023)
11.7.5 IRM Europe Recent Developments
11.8 Marken
11.8.1 Marken Company Details
11.8.2 Marken Business Overview
11.8.3 Marken Clinical Trial Equipment & Ancillary Solutions Introduction
11.8.4 Marken Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2018-2023)
11.8.5 Marken Recent Developments
11.9 Myonex
11.9.1 Myonex Company Details
11.9.2 Myonex Business Overview
11.9.3 Myonex Clinical Trial Equipment & Ancillary Solutions Introduction
11.9.4 Myonex Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2018-2023)
11.9.5 Myonex Recent Developments
11.10 Parexel International
11.10.1 Parexel International Company Details
11.10.2 Parexel International Business Overview
11.10.3 Parexel International Clinical Trial Equipment & Ancillary Solutions Introduction
11.10.4 Parexel International Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2018-2023)
11.10.5 Parexel International Recent Developments
11.11 Piramal Pharma
11.11.1 Piramal Pharma Company Details
11.11.2 Piramal Pharma Business Overview
11.11.3 Piramal Pharma Clinical Trial Equipment & Ancillary Solutions Introduction
11.11.4 Piramal Pharma Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2018-2023)
11.11.5 Piramal Pharma Recent Developments
11.12 Recipharm
11.12.1 Recipharm Company Details
11.12.2 Recipharm Business Overview
11.12.3 Recipharm Clinical Trial Equipment & Ancillary Solutions Introduction
11.12.4 Recipharm Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2018-2023)
11.12.5 Recipharm Recent Developments
11.13 Thermo Fisher Scientific
11.13.1 Thermo Fisher Scientific Company Details
11.13.2 Thermo Fisher Scientific Business Overview
11.13.3 Thermo Fisher Scientific Clinical Trial Equipment & Ancillary Solutions Introduction
11.13.4 Thermo Fisher Scientific Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2018-2023)
11.13.5 Thermo Fisher Scientific Recent Developments
11.14 Woodley Equipment
11.14.1 Woodley Equipment Company Details
11.14.2 Woodley Equipment Business Overview
11.14.3 Woodley Equipment Clinical Trial Equipment & Ancillary Solutions Introduction
11.14.4 Woodley Equipment Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2018-2023)
11.14.5 Woodley Equipment Recent Developments
11.15 Quipment SAS
11.15.1 Quipment SAS Company Details
11.15.2 Quipment SAS Business Overview
11.15.3 Quipment SAS Clinical Trial Equipment & Ancillary Solutions Introduction
11.15.4 Quipment SAS Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2018-2023)
11.15.5 Quipment SAS Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

 

ページTOPに戻る


 

Summary

Market Analysis and Insights: Global Clinical Trial Equipment & Ancillary Solutions Market
The global Clinical Trial Equipment & Ancillary Solutions market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Clinical Trial Equipment & Ancillary Solutions is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Clinical Trial Equipment & Ancillary Solutions is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Clinical Trial Equipment & Ancillary Solutions is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of Clinical Trial Equipment & Ancillary Solutions include Almac, Ancillare, Avantor, Emsere, Eurofins Scientific, Imperial Clinical Research Services, IRM Europe, Marken and Myonex, etc. in 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes
This report presents an overview of global market for Clinical Trial Equipment & Ancillary Solutions market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Clinical Trial Equipment & Ancillary Solutions, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Clinical Trial Equipment & Ancillary Solutions, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Clinical Trial Equipment & Ancillary Solutions revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Clinical Trial Equipment & Ancillary Solutions market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Clinical Trial Equipment & Ancillary Solutions revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Almac, Ancillare, Avantor, Emsere, Eurofins Scientific, Imperial Clinical Research Services, IRM Europe, Marken and Myonex, etc.

By Company
Almac
Ancillare
Avantor
Emsere
Eurofins Scientific
Imperial Clinical Research Services
IRM Europe
Marken
Myonex
Parexel International
Piramal Pharma
Recipharm
Thermo Fisher Scientific
Woodley Equipment
Quipment SAS
Segment by Type
Biologic Drugs
Small Molecules
Medical Devices
Segment by Application
Contract Research Organizations (CROs)
Medical Devices Companies
Pharmaceutical & Biotechnology Companies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Clinical Trial Equipment & Ancillary Solutions in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Trial Equipment & Ancillary Solutions companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Clinical Trial Equipment & Ancillary Solutions revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions



ページTOPに戻る


Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Trial Equipment & Ancillary Solutions Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Biologic Drugs
1.2.3 Small Molecules
1.2.4 Medical Devices
1.3 Market by Application
1.3.1 Global Clinical Trial Equipment & Ancillary Solutions Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Contract Research Organizations (CROs)
1.3.3 Medical Devices Companies
1.3.4 Pharmaceutical & Biotechnology Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Trial Equipment & Ancillary Solutions Market Perspective (2018-2029)
2.2 Global Clinical Trial Equipment & Ancillary Solutions Growth Trends by Region
2.2.1 Clinical Trial Equipment & Ancillary Solutions Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Clinical Trial Equipment & Ancillary Solutions Historic Market Size by Region (2018-2023)
2.2.3 Clinical Trial Equipment & Ancillary Solutions Forecasted Market Size by Region (2024-2029)
2.3 Clinical Trial Equipment & Ancillary Solutions Market Dynamics
2.3.1 Clinical Trial Equipment & Ancillary Solutions Industry Trends
2.3.2 Clinical Trial Equipment & Ancillary Solutions Market Drivers
2.3.3 Clinical Trial Equipment & Ancillary Solutions Market Challenges
2.3.4 Clinical Trial Equipment & Ancillary Solutions Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Clinical Trial Equipment & Ancillary Solutions by Players
3.1.1 Global Clinical Trial Equipment & Ancillary Solutions Revenue by Players (2018-2023)
3.1.2 Global Clinical Trial Equipment & Ancillary Solutions Revenue Market Share by Players (2018-2023)
3.2 Global Clinical Trial Equipment & Ancillary Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Clinical Trial Equipment & Ancillary Solutions, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Clinical Trial Equipment & Ancillary Solutions Market Concentration Ratio
3.4.1 Global Clinical Trial Equipment & Ancillary Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Trial Equipment & Ancillary Solutions Revenue in 2022
3.5 Global Key Players of Clinical Trial Equipment & Ancillary Solutions Head office and Area Served
3.6 Global Key Players of Clinical Trial Equipment & Ancillary Solutions, Product and Application
3.7 Global Key Players of Clinical Trial Equipment & Ancillary Solutions, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Trial Equipment & Ancillary Solutions Breakdown Data by Type
4.1 Global Clinical Trial Equipment & Ancillary Solutions Historic Market Size by Type (2018-2023)
4.2 Global Clinical Trial Equipment & Ancillary Solutions Forecasted Market Size by Type (2024-2029)
5 Clinical Trial Equipment & Ancillary Solutions Breakdown Data by Application
5.1 Global Clinical Trial Equipment & Ancillary Solutions Historic Market Size by Application (2018-2023)
5.2 Global Clinical Trial Equipment & Ancillary Solutions Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Clinical Trial Equipment & Ancillary Solutions Market Size (2018-2029)
6.2 North America Clinical Trial Equipment & Ancillary Solutions Market Size by Type
6.2.1 North America Clinical Trial Equipment & Ancillary Solutions Market Size by Type (2018-2023)
6.2.2 North America Clinical Trial Equipment & Ancillary Solutions Market Size by Type (2024-2029)
6.2.3 North America Clinical Trial Equipment & Ancillary Solutions Market Share by Type (2018-2029)
6.3 North America Clinical Trial Equipment & Ancillary Solutions Market Size by Application
6.3.1 North America Clinical Trial Equipment & Ancillary Solutions Market Size by Application (2018-2023)
6.3.2 North America Clinical Trial Equipment & Ancillary Solutions Market Size by Application (2024-2029)
6.3.3 North America Clinical Trial Equipment & Ancillary Solutions Market Share by Application (2018-2029)
6.4 North America Clinical Trial Equipment & Ancillary Solutions Market Size by Country
6.4.1 North America Clinical Trial Equipment & Ancillary Solutions Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2018-2023)
6.4.3 North America Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Clinical Trial Equipment & Ancillary Solutions Market Size (2018-2029)
7.2 Europe Clinical Trial Equipment & Ancillary Solutions Market Size by Type
7.2.1 Europe Clinical Trial Equipment & Ancillary Solutions Market Size by Type (2018-2023)
7.2.2 Europe Clinical Trial Equipment & Ancillary Solutions Market Size by Type (2024-2029)
7.2.3 Europe Clinical Trial Equipment & Ancillary Solutions Market Share by Type (2018-2029)
7.3 Europe Clinical Trial Equipment & Ancillary Solutions Market Size by Application
7.3.1 Europe Clinical Trial Equipment & Ancillary Solutions Market Size by Application (2018-2023)
7.3.2 Europe Clinical Trial Equipment & Ancillary Solutions Market Size by Application (2024-2029)
7.3.3 Europe Clinical Trial Equipment & Ancillary Solutions Market Share by Application (2018-2029)
7.4 Europe Clinical Trial Equipment & Ancillary Solutions Market Size by Country
7.4.1 Europe Clinical Trial Equipment & Ancillary Solutions Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2018-2023)
7.4.3 Europe Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Clinical Trial Equipment & Ancillary Solutions Market Size (2018-2029)
8.2 China Clinical Trial Equipment & Ancillary Solutions Market Size by Type
8.2.1 China Clinical Trial Equipment & Ancillary Solutions Market Size by Type (2018-2023)
8.2.2 China Clinical Trial Equipment & Ancillary Solutions Market Size by Type (2024-2029)
8.2.3 China Clinical Trial Equipment & Ancillary Solutions Market Share by Type (2018-2029)
8.3 China Clinical Trial Equipment & Ancillary Solutions Market Size by Application
8.3.1 China Clinical Trial Equipment & Ancillary Solutions Market Size by Application (2018-2023)
8.3.2 China Clinical Trial Equipment & Ancillary Solutions Market Size by Application (2024-2029)
8.3.3 China Clinical Trial Equipment & Ancillary Solutions Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Clinical Trial Equipment & Ancillary Solutions Market Size (2018-2029)
9.2 Asia Clinical Trial Equipment & Ancillary Solutions Market Size by Type
9.2.1 Asia Clinical Trial Equipment & Ancillary Solutions Market Size by Type (2018-2023)
9.2.2 Asia Clinical Trial Equipment & Ancillary Solutions Market Size by Type (2024-2029)
9.2.3 Asia Clinical Trial Equipment & Ancillary Solutions Market Share by Type (2018-2029)
9.3 Asia Clinical Trial Equipment & Ancillary Solutions Market Size by Application
9.3.1 Asia Clinical Trial Equipment & Ancillary Solutions Market Size by Application (2018-2023)
9.3.2 Asia Clinical Trial Equipment & Ancillary Solutions Market Size by Application (2024-2029)
9.3.3 Asia Clinical Trial Equipment & Ancillary Solutions Market Share by Application (2018-2029)
9.4 Asia Clinical Trial Equipment & Ancillary Solutions Market Size by Region
9.4.1 Asia Clinical Trial Equipment & Ancillary Solutions Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Clinical Trial Equipment & Ancillary Solutions Market Size by Region (2018-2023)
9.4.3 Asia Clinical Trial Equipment & Ancillary Solutions Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Clinical Trial Equipment & Ancillary Solutions Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Clinical Trial Equipment & Ancillary Solutions Market Size by Type
10.2.1 Middle East, Africa, and Latin America Clinical Trial Equipment & Ancillary Solutions Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Clinical Trial Equipment & Ancillary Solutions Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Clinical Trial Equipment & Ancillary Solutions Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Clinical Trial Equipment & Ancillary Solutions Market Size by Application
10.3.1 Middle East, Africa, and Latin America Clinical Trial Equipment & Ancillary Solutions Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Clinical Trial Equipment & Ancillary Solutions Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Clinical Trial Equipment & Ancillary Solutions Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Clinical Trial Equipment & Ancillary Solutions Market Size by Country
10.4.1 Middle East, Africa, and Latin America Clinical Trial Equipment & Ancillary Solutions Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Almac
11.1.1 Almac Company Details
11.1.2 Almac Business Overview
11.1.3 Almac Clinical Trial Equipment & Ancillary Solutions Introduction
11.1.4 Almac Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2018-2023)
11.1.5 Almac Recent Developments
11.2 Ancillare
11.2.1 Ancillare Company Details
11.2.2 Ancillare Business Overview
11.2.3 Ancillare Clinical Trial Equipment & Ancillary Solutions Introduction
11.2.4 Ancillare Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2018-2023)
11.2.5 Ancillare Recent Developments
11.3 Avantor
11.3.1 Avantor Company Details
11.3.2 Avantor Business Overview
11.3.3 Avantor Clinical Trial Equipment & Ancillary Solutions Introduction
11.3.4 Avantor Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2018-2023)
11.3.5 Avantor Recent Developments
11.4 Emsere
11.4.1 Emsere Company Details
11.4.2 Emsere Business Overview
11.4.3 Emsere Clinical Trial Equipment & Ancillary Solutions Introduction
11.4.4 Emsere Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2018-2023)
11.4.5 Emsere Recent Developments
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Details
11.5.2 Eurofins Scientific Business Overview
11.5.3 Eurofins Scientific Clinical Trial Equipment & Ancillary Solutions Introduction
11.5.4 Eurofins Scientific Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2018-2023)
11.5.5 Eurofins Scientific Recent Developments
11.6 Imperial Clinical Research Services
11.6.1 Imperial Clinical Research Services Company Details
11.6.2 Imperial Clinical Research Services Business Overview
11.6.3 Imperial Clinical Research Services Clinical Trial Equipment & Ancillary Solutions Introduction
11.6.4 Imperial Clinical Research Services Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2018-2023)
11.6.5 Imperial Clinical Research Services Recent Developments
11.7 IRM Europe
11.7.1 IRM Europe Company Details
11.7.2 IRM Europe Business Overview
11.7.3 IRM Europe Clinical Trial Equipment & Ancillary Solutions Introduction
11.7.4 IRM Europe Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2018-2023)
11.7.5 IRM Europe Recent Developments
11.8 Marken
11.8.1 Marken Company Details
11.8.2 Marken Business Overview
11.8.3 Marken Clinical Trial Equipment & Ancillary Solutions Introduction
11.8.4 Marken Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2018-2023)
11.8.5 Marken Recent Developments
11.9 Myonex
11.9.1 Myonex Company Details
11.9.2 Myonex Business Overview
11.9.3 Myonex Clinical Trial Equipment & Ancillary Solutions Introduction
11.9.4 Myonex Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2018-2023)
11.9.5 Myonex Recent Developments
11.10 Parexel International
11.10.1 Parexel International Company Details
11.10.2 Parexel International Business Overview
11.10.3 Parexel International Clinical Trial Equipment & Ancillary Solutions Introduction
11.10.4 Parexel International Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2018-2023)
11.10.5 Parexel International Recent Developments
11.11 Piramal Pharma
11.11.1 Piramal Pharma Company Details
11.11.2 Piramal Pharma Business Overview
11.11.3 Piramal Pharma Clinical Trial Equipment & Ancillary Solutions Introduction
11.11.4 Piramal Pharma Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2018-2023)
11.11.5 Piramal Pharma Recent Developments
11.12 Recipharm
11.12.1 Recipharm Company Details
11.12.2 Recipharm Business Overview
11.12.3 Recipharm Clinical Trial Equipment & Ancillary Solutions Introduction
11.12.4 Recipharm Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2018-2023)
11.12.5 Recipharm Recent Developments
11.13 Thermo Fisher Scientific
11.13.1 Thermo Fisher Scientific Company Details
11.13.2 Thermo Fisher Scientific Business Overview
11.13.3 Thermo Fisher Scientific Clinical Trial Equipment & Ancillary Solutions Introduction
11.13.4 Thermo Fisher Scientific Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2018-2023)
11.13.5 Thermo Fisher Scientific Recent Developments
11.14 Woodley Equipment
11.14.1 Woodley Equipment Company Details
11.14.2 Woodley Equipment Business Overview
11.14.3 Woodley Equipment Clinical Trial Equipment & Ancillary Solutions Introduction
11.14.4 Woodley Equipment Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2018-2023)
11.14.5 Woodley Equipment Recent Developments
11.15 Quipment SAS
11.15.1 Quipment SAS Company Details
11.15.2 Quipment SAS Business Overview
11.15.3 Quipment SAS Clinical Trial Equipment & Ancillary Solutions Introduction
11.15.4 Quipment SAS Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2018-2023)
11.15.5 Quipment SAS Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD(clinical trial)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15 10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る